Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel Epigenetic Target Therapy for Prostate Cancer: A Preclinical Study
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 5, Pages e98101
Publisher
Public Library of Science (PLoS)
Online
2014-05-23
DOI
10.1371/journal.pone.0098101
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Magnetic nanoparticles as new diagnostic tools in medicine
- (2013) K Niemirowicz et al. Advances in Medical Sciences
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Efficacy of decitabine-loaded nanogels in overcoming cancer drug resistance is mediated via sustained DNA methyltransferase 1 (DNMT1) depletion
- (2013) Sivakumar Vijayaraghavalu et al. CANCER LETTERS
- Zebularine partially reverses GST methylation in prostate cancer cells and restores sensitivity to the DNA minor groove binder brostallicin
- (2013) Maria Antonietta Sabatino et al. Epigenetics
- Deregulated expression of urokinase and its inhibitor type 1 in prostate cancer cells: Role of epigenetic mechanisms
- (2013) Albert Hagelgans et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The Finely Regulating Well-defined Functional Polymeric Nanocarriers for Anti-tumor Immunotherapy
- (2013) Wei Li et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Pharmacokinetic and pharmacodynamic analysis of 5-aza-2’-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy
- (2013) Metin Karahoca et al. Clinical Epigenetics
- Epigenetic Therapy of Non-Small Cell Lung Cancer Using Decitabine (5-Aza-2′-Deoxycytidine)
- (2013) Richard L. Momparler Frontiers in Oncology
- Targeting the Unique Methylation Pattern of Androgen Receptor (AR) Promoter in Prostate Stem/Progenitor Cells with 5-Aza-2′-deoxycytidine (5-AZA) Leads to Suppressed Prostate Tumorigenesis
- (2012) Jing Tian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acute Hypersensitivity of Pluripotent Testicular Cancer-Derived Embryonal Carcinoma to Low-Dose 5-Aza Deoxycytidine Is Associated with Global DNA Damage-Associated p53 Activation, Anti-Pluripotency and DNA Demethylation
- (2012) Bijesh K. Biswal et al. PLoS One
- DNMT (DNA methyltransferase) inhibitors radiosensitize human cancer cells by suppressing DNA repair activity
- (2012) Hak Jae Kim et al. Radiation Oncology
- Erythrocyte-Inspired Delivery Systems
- (2012) Che-Ming J. Hu et al. Advanced Healthcare Materials
- The role of surgery in high-risk localised prostate cancer
- (2011) Vincent J. Gnanapragasam et al. BJU INTERNATIONAL
- Prostate cancer in the elderly
- (2011) Emil Scosyrev et al. CANCER
- Cancer epigenetics: linking basic biology to clinical medicine
- (2011) Hsing-Chen Tsai et al. CELL RESEARCH
- Molecular Alterations during Progression of Prostate Cancer to Androgen Independence
- (2011) P. Saraon et al. CLINICAL CHEMISTRY
- Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space
- (2011) A Oliver Sartor Journal of Hematology & Oncology
- Newly Engineered Magnetic Erythrocytes for Sustained and Targeted Delivery of Anti-Cancer Therapeutic Compounds
- (2011) Caterina Cinti et al. PLoS One
- GSTP1 DNA Methylation and Expression Status Is Indicative of 5-aza-2′-Deoxycytidine Efficacy in Human Prostate Cancer Cells
- (2011) Karen Chiam et al. PLoS One
- 5-Aza-2′-deoxycytidine stress response and apoptosis in prostate cancer
- (2011) Aditi Patra et al. Clinical Epigenetics
- Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists
- (2010) David Mossman et al. BMC CANCER
- Coding of facial expressions of pain in the laboratory mouse
- (2010) Dale J Langford et al. NATURE METHODS
- The promises and pitfalls of epigenetic therapies in solid tumours
- (2009) Janet S. Graham et al. EUROPEAN JOURNAL OF CANCER
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNMT1 as a Molecular Target in a Multimodality-Resistant Phenotype in Tumor Cells
- (2008) M. V. Mishra et al. MOLECULAR CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now